• obsessive compulsive disorder market dynamics indicate upward trajectory through 2034, reports delveinsight | biohaven pharma, abb... Barchart.com Mon, 29 Sep 2025 15:02:29 GMT
• obsessive compulsive disorder market dynamics indicate upward trajectory through 2034, reports delveinsight | biohaven pharma, abb... Barchart.com Fri, 26 Sep 2025 14:52:00 GMT
• biohaven pharmaceuticals prepares for vyglxia launch pending fda approval for spinocerebellar ataxia treatment geneonline.com Mon, 08 Sep 2025 03:09:23 GMT
• biohaven pharmaceuticals prepares for vyglxia distribution pending fda approval for spinocerebellar ataxia treatment geneonline.com Sun, 07 Sep 2025 19:59:47 GMT
• biohaven pharmaceuticals announces immediate distribution of fda-approved spinocerebellar ataxia drug vyglxia geneonline.com Sun, 07 Sep 2025 14:14:30 GMT
• biohaven pharmaceuticals prepares for immediate distribution of vyglxia pending fda approval for spinocerebellar ataxia treatment geneonline.com Sun, 07 Sep 2025 01:07:35 GMT
• biohaven pharmaceuticals announces fda approval and immediate distribution of vyglxia for spinocerebellar ataxia treatment geneonline.com Sat, 06 Sep 2025 15:08:53 GMT
• biohaven pharmaceuticals prepares for vyglxia launch pending fda approval for spinocerebellar ataxia treatment geneonline.com Sat, 06 Sep 2025 12:02:27 GMT
• biohaven pharmaceuticals prepares for immediate distribution of vyglxia pending fda approval geneonline.com Sat, 06 Sep 2025 07:00:00 GMT
• Biohaven’s rare disease drug is ‘ready to ship on Day 1’ following FDA approval BioPharma Dive Wed, 03 Sep 2025 07:00:00 GMT
• price momentum metrics for biohaven ltd. explained - quarterly trade report & proven capital preservation methods Newser Thu, 28 Aug 2025 15:26:19 GMT
• BRIEF—FDA drops need for AdCom on Biohaven’s troriluzole The Pharma Letter Tue, 26 Aug 2025 07:00:00 GMT
• spinocerebellar ataxias clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline | biohaven ph... Barchart.com Tue, 26 Aug 2025 07:00:00 GMT
• focal epilepsy market: epidemiology, pipeline, companies, delveinsight | biocodex, biohaven therapeutics ltd., xenon pharmaceutica... Barchart.com Tue, 26 Aug 2025 00:34:18 GMT
• biohaven: despite troriluzole program delay, fda review on track for q4 2025 (nyse:bhvn) Seeking Alpha Mon, 25 Aug 2025 07:00:00 GMT
• focal epilepsy market: epidemiology, pipeline, companies, delveinsight | biocodex, biohaven therapeutics ltd., xenon pharmaceutica... Barchart.com Mon, 25 Aug 2025 07:00:00 GMT
• what to do if you’re stuck in biohaven ltd. - weekly market outlook & precise swing trade alerts Newser Sat, 23 Aug 2025 19:54:16 GMT
• FDA cancels adcomm on Biohaven drug; Catalent lays off staff BioPharma Dive Fri, 22 Aug 2025 07:00:00 GMT
• Biohaven rises as FDA cancels AdCom on lead drug (BHVN:NYSE) Seeking Alpha Fri, 22 Aug 2025 07:00:00 GMT
• biohaven says it won’t have to face fda adcomm for its sca drug Endpoints News Fri, 22 Aug 2025 07:00:00 GMT
• biohaven says fda will not hold advisory meeting for troriluzole application Investing.com Fri, 22 Aug 2025 07:00:00 GMT
• biohaven shares jump as fda cancels advisory meeting for rare disease drug Investing.com Fri, 22 Aug 2025 07:00:00 GMT
• motor neuron disease clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analysis | bioha... Barchart.com Thu, 21 Aug 2025 07:00:00 GMT
• motor neuron disease clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analysis | bioha... Barchart.com Wed, 20 Aug 2025 14:01:00 GMT
• jazz pharma broadens its prospects in epilepsy with deal for selective saniona drug MedCity News Wed, 20 Aug 2025 07:00:00 GMT
• chart based analysis of biohaven ltd. trends - bear alert & daily entry point trade alerts Newser Sun, 17 Aug 2025 02:23:39 GMT
• Biohaven files prospectus for resale of 3.6 million shares tied to Knopp deal Investing.com Fri, 15 Aug 2025 07:00:00 GMT
• biohaven's share resale and knopp amendment: implications for liquidity and governance risk AInvest Fri, 15 Aug 2025 07:00:00 GMT
• how legal challenges over drug pipeline disclosures at biohaven (bhvn) have changed its investment story simplywall.st Thu, 14 Aug 2025 07:00:00 GMT
• Biohaven trashes troriluzole in OCD after asset bungles phase 3 trial Fierce Biotech Tue, 12 Aug 2025 07:00:00 GMT
• Biohaven scraps Phase 3 OCD program; Fosun’s licensing deal with Expedition Endpoints News Tue, 12 Aug 2025 07:00:00 GMT
• biohaven pharmaceutical stock price target lowered to $30 at h.c. wainwright Investing.com UK Tue, 12 Aug 2025 07:00:00 GMT
• biohaven ltd. shares fall 1.79% premarket after reporting q2 earnings. AInvest Tue, 12 Aug 2025 07:00:00 GMT
• dilated cardiomyopathy clinical trials, companies, therapeutic assessment, emerging therapies, treatment algorithm, and pipeline a... Barchart.com Mon, 11 Aug 2025 21:34:31 GMT
• biohaven reports second quarter 2025 financial results and recent business developments PR Newswire Mon, 11 Aug 2025 07:00:00 GMT
• biohaven pharmaceuticals plunges 1.69% as class-action lawsuit alleges misleading drug claims AInvest Wed, 30 Jul 2025 07:00:00 GMT
• obsessive compulsive disorder clinical trials 2025: ema, pdma, fda approvals, medication, pipeline, therapies, mechanism of action... The Globe and Mail Tue, 22 Jul 2025 10:47:14 GMT
• biohaven’s volatility: a sudden surge amid regulatory turmoil AInvest Thu, 17 Jul 2025 07:00:00 GMT
• biohaven's regulatory labyrinth: can the stock survive the delays and litigation? AInvest Thu, 17 Jul 2025 01:26:06 GMT
• biohaven, bexorg partner to accelerate cns drug discovery using novel whole-brain platform MSN Wed, 16 Jul 2025 13:58:39 GMT
• biohaven's regulatory labyrinth: can the stock survive the delays and litigation? AInvest Wed, 16 Jul 2025 07:00:00 GMT
• Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform Yahoo Finance Tue, 15 Jul 2025 07:00:00 GMT
• biohaven and bexorg: pioneering a new era in cns drug development AInvest Tue, 15 Jul 2025 07:00:00 GMT
• biohaven pharmaceutical stock hits 52-week low at 13.68 usd by investing.com Investing.com UK Tue, 15 Jul 2025 07:00:00 GMT
• spinocerebellar ataxias pipeline 2025: moa, roa, and clinical trial insights explored by delveinsight | biogen inc, bioxcel corp, ... Barchart.com Mon, 14 Jul 2025 14:06:05 GMT
• motor neuron disease clinical trials, companies, therapeutic openPR.com Fri, 11 Jul 2025 07:00:00 GMT
• novel glp-1/gip agent led to weight loss with once-monthly dosing MedPage Today Mon, 23 Jun 2025 07:00:00 GMT
• spinocerebellar ataxia: pipeline drugs and emerging therapies openPR.com Tue, 17 Jun 2025 07:00:00 GMT
• bexorg announces research collaboration with biohaven leveraging its novel ai-driven whole-brain discovery platform to enhance cns... Yahoo Finance Tue, 10 Jun 2025 07:00:00 GMT
• biohaven and bexorg: pioneering a new frontier in neurodegenerative drug development AInvest Tue, 10 Jun 2025 07:00:00 GMT
• bexorg-biohaven: a paradigm shift in cns drug discovery through ai-driven synergy AInvest Tue, 10 Jun 2025 07:00:00 GMT
• abcuro hires ex-alexion, biohaven exec to lead commercial team ahead of planned launch Fierce Pharma Mon, 09 Jun 2025 07:00:00 GMT
• biohaven ltd. highlights strategic focus in investor presentation TipRanks Wed, 04 Jun 2025 07:00:00 GMT
• TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN' StreetInsider Thu, 29 May 2025 07:00:00 GMT
• Breakthrough Parkinson's Treatment: Biohaven's Novel Brain Drug Enters Pivotal Trial for 10M Patients Stock Titan Thu, 29 May 2025 07:00:00 GMT
• biohaven enrolls first patient into phase 2/3 trial in early parkinson's disease, targeting neuroinflammation with novel brain-pen... PR Newswire Thu, 29 May 2025 07:00:00 GMT
• biohaven says anti-cancer agent cut tumor size (bhvn:nyse) Seeking Alpha Wed, 28 May 2025 18:44:00 GMT
• biohaven pharma (bhvn) presents oncology program updates and preliminary clinical data showcasing innovative trop2 and fgfr3 antib... StreetInsider Wed, 28 May 2025 11:33:12 GMT
• Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conju... PR Newswire Wed, 28 May 2025 07:00:00 GMT
• Biohaven Pharma (BHVN) Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day StreetInsider Wed, 28 May 2025 07:00:00 GMT
• breakthrough: biohaven's new cancer drug achieves perfect response rate in first 6 patients treated Stock Titan Wed, 28 May 2025 07:00:00 GMT
• biohaven says anti-cancer agent cut tumor size with regeneron’s libtayo in phase 1 trial Seeking Alpha Wed, 28 May 2025 07:00:00 GMT
• breakthrough iga nephropathy treatment achieves 81% disease marker reduction in first-in-class trial Stock Titan Wed, 28 May 2025 07:00:00 GMT
• biohaven highlights innovation and advancement across mode and trap degrader platform at r&d day, announcing positive trap degrade... PR Newswire Wed, 28 May 2025 07:00:00 GMT
• inozyme pharma and biohaven pharmaceuticals announce leadership changes amid industry restructuring geneonline.com Mon, 26 May 2025 07:00:00 GMT
• biotech tumbles on a surprise fda twist for its rare-disease drug Investor's Business Daily Thu, 15 May 2025 20:22:00 GMT
• Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug Investor's Business Daily Thu, 15 May 2025 07:00:00 GMT
• FDA delays decision on Biohaven's rare disease drug filing, plans adcomm Fierce Biotech Thu, 15 May 2025 07:00:00 GMT
• FDA delays approval decision for Biohaven rare disease drug BioPharma Dive Thu, 15 May 2025 07:00:00 GMT
• Biohaven stock slides as FDA delays drug review (BHVN:NYSE) Seeking Alpha Thu, 15 May 2025 07:00:00 GMT
• fda delays decision date on biohaven’s spinocerebellar ataxia application BioSpace Thu, 15 May 2025 07:00:00 GMT
• FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia PR Newswire Wed, 14 May 2025 07:00:00 GMT
• Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments PR Newswire Mon, 12 May 2025 07:00:00 GMT
• trigeminal neuralgia market predicted to see upsurge through 2032, highlights delveinsight | noema pharma ag, biohaven pharmaceuti... Barchart.com Fri, 09 May 2025 14:44:00 GMT
• facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously BioPharma Dive Tue, 06 May 2025 16:23:16 GMT
• Biohaven secures $600m financing as it awaits FDA prodrug decision Pharmaceutical Technology Tue, 29 Apr 2025 07:00:00 GMT
• biohaven grabs a foothold with $600m windfall from oberland capital BioSpace Tue, 29 Apr 2025 07:00:00 GMT
• Biohaven Announces Investment up to $600 Million by Oberland Capital PR Newswire Mon, 28 Apr 2025 07:00:00 GMT
• Biohaven, after setbacks, sees shares jump with Oberland Capital funding agreement worth up to $600M Fierce Biotech Mon, 28 Apr 2025 07:00:00 GMT
• Biohaven secures $600M financing ahead of FDA verdict on ataxia drug FirstWord Pharma Mon, 28 Apr 2025 07:00:00 GMT
• biohaven pharma (bhvn) announces investment up to $600 million by oberland capital StreetInsider Mon, 28 Apr 2025 07:00:00 GMT
• biohaven lands massive $600m backing to advance first-ever treatment for rare genetic disease Stock Titan Mon, 28 Apr 2025 07:00:00 GMT
• biohaven's pipeline potential outshines near-term setbacks, says rbc capital AInvest Sat, 26 Apr 2025 07:00:00 GMT
• biohaven pharma stock tumbles after withdrawal of dazluma application in eu Investing.com Australia Sat, 26 Apr 2025 07:00:00 GMT
• biohaven drops after pulling eu marketing application for rare disorder drug MSN Fri, 25 Apr 2025 16:51:50 GMT
• Biohaven stock slides on withdrawal of European marketing application BioPharma Dive Fri, 25 Apr 2025 07:00:00 GMT
• biohaven pharma stock tumbles after withdrawal of dazluma application in eu Investing.com Nigeria Fri, 25 Apr 2025 07:00:00 GMT
• biohaven pharmaceutical : announces pricing of $250 million public offering of common shares marketscreener.com Sat, 19 Apr 2025 14:48:46 GMT
• Biohaven’s BHV-8000 rescues locomotor deficits in Parkinson’s disease BioWorld MedTech Thu, 17 Apr 2025 07:00:00 GMT
• biohaven’s bhv-1310 shows promise for autoimmune disorders BioWorld MedTech Wed, 16 Apr 2025 07:00:00 GMT
• biohaven pharmaceutical : enrolls first patient in phase 2 clinical trial of rimegepant, oral cgrp receptor antagonist, for treatm... marketscreener.com Mon, 14 Apr 2025 12:00:04 GMT
• why biotech stocks such as biohaven, recursion pharmaceuticals, and crispr therapeutics plunged in march MSN Wed, 09 Apr 2025 10:57:13 GMT
• royalty pharma expands board with biohaven ceo appointment by investing.com Investing.com India Wed, 09 Apr 2025 07:00:00 GMT
• royalty pharma expands board with biohaven ceo appointment Investing.com Tue, 08 Apr 2025 07:00:00 GMT
• biotech leader behind $13b pfizer-biohaven deal takes strategic role at royalty pharma Stock Titan Tue, 08 Apr 2025 07:00:00 GMT
• novel bispecific degrader bhv-1310 eliminates intravascular and interstitial igg within multiple organs and anatomical structures ... Neurology® Journals Mon, 07 Apr 2025 07:00:00 GMT
• Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March Nasdaq Thu, 03 Apr 2025 07:00:00 GMT
• pfizer's $11.6 billion biohaven buy could spark more biotech deals MarketScreener Mon, 31 Mar 2025 15:45:45 GMT
• multiple system atrophy market to reach new heights in growth by 2034, delveinsight predicts | ionis pharma, biohaven pharma, lund... Barchart Thu, 20 Mar 2025 13:03:01 GMT
• biohaven's verdiperstat receives fast track designation for the treatment of multiple system atrophy Reuters Tue, 18 Mar 2025 07:00:00 GMT
• morgan stanley cuts biohaven stock price target to $63 from $69 Investing.com Thu, 06 Mar 2025 08:00:00 GMT
• biohaven pharmaceutical holding (bhvn) pt lowered to $63 at jefferies StreetInsider Wed, 05 Mar 2025 08:00:00 GMT
• Biohaven’s pivotal bipolar drug trial fails, stock takes hit Clinical Trials Arena Tue, 04 Mar 2025 08:00:00 GMT
• Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data BioPharma Dive Tue, 04 Mar 2025 08:00:00 GMT
• Colorado Doctors Allegedly Accepted Illegal Kickbacks in Migraine Drug Scheme longmontleader.com Tue, 04 Mar 2025 08:00:00 GMT
• biohaven disappoints again, this time in phase ii/iii bipolar mania trial BioSpace Tue, 04 Mar 2025 08:00:00 GMT
• biohaven’s biopolar candidate fails to improve mania in pivotal trial Fierce Biotech Mon, 03 Mar 2025 22:14:43 GMT
• Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results PR Newswire Mon, 03 Mar 2025 08:00:00 GMT
• UPDATE: Biohaven's bipolar candidate fails to improve mania in pivotal trial Fierce Biotech Mon, 03 Mar 2025 08:00:00 GMT
• Biohaven skids after BHV-7000 bipolar study failure FirstWord Pharma Mon, 03 Mar 2025 08:00:00 GMT
• biohaven reports positive degrader data achieving > 80% sustained reductions in total igg with potential first-in-class bhv-1300 PR Newswire Mon, 03 Mar 2025 08:00:00 GMT
• biohaven pharma (bhvn) reports positive degrader data achieving > 80% sustained reductions in total igg with potential first-in-cl... StreetInsider Mon, 03 Mar 2025 08:00:00 GMT
• can biohaven's fda priority review and $489m cash position fuel its ambitious pipeline? Stock Titan Mon, 03 Mar 2025 08:00:00 GMT
• biohaven’s ion channel drug fails pivotal bipolar mania study Endpoints News Mon, 03 Mar 2025 08:00:00 GMT
• Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ata... PR Newswire Tue, 11 Feb 2025 08:00:00 GMT
• Biohaven Just Hurdled An FDA Setback — And Its Moving Lines Investor's Business Daily Tue, 11 Feb 2025 08:00:00 GMT
• merck kgaa pursuing springworks; bridgebio wins eu drug ok BioPharma Dive Tue, 11 Feb 2025 08:00:00 GMT
• biohaven's troriluzole stuns with 70% sca progression slowdown - fda priority review granted Stock Titan Tue, 11 Feb 2025 08:00:00 GMT
• biohaven lands priority review on second-chance application for neurodegenerative drug Endpoints News Tue, 11 Feb 2025 08:00:00 GMT
• biohaven’s transformative leap: pioneering pharmaceutical progress StocksToTrade Tue, 11 Feb 2025 08:00:00 GMT
• biohaven pharma (bhvn) announces fda acceptance and priority review of troriluzole nda StreetInsider Tue, 11 Feb 2025 08:00:00 GMT
• epilepsy market expected to rise, 2034 | xenon pharmaceuticals, aquestive therapeutics, atnahs pharma (pharmanovia), takeda, ovid ... Barchart Thu, 06 Feb 2025 00:32:03 GMT
• Attorney General’s Office secures $2.3M in multistate action from Pfizer-owned company Florida Politics Wed, 05 Feb 2025 08:00:00 GMT
• epilepsy market expected to rise, 2034 | xenon pharmaceuticals, aquestive therapeutics, atnahs pharma (pharmanovia), takeda, ovid ... Barchart.com Wed, 05 Feb 2025 08:00:00 GMT
• attorney general tong announces $59 million false claims settlement with pfizer-owned biohaven CT.GOV-Connecticut's Official State Website (.gov) Tue, 04 Feb 2025 08:00:00 GMT
• attorney general bonta announces nearly $60 million settlement against pfizer-owned pharmaceutical holding company, biohaven State of California - Department of Justice (.gov) Mon, 03 Feb 2025 08:00:00 GMT
• Pfizer to pay nearly $60M over kickbacks for migraine drug developed by New Haven-based Biohaven Hartford Business Journal Wed, 29 Jan 2025 08:00:00 GMT
• pfizer’s subsidiary biohaven settles for nearly $60m over speaker programs: complaint included significant open payments under rep... CCO Wed, 29 Jan 2025 08:00:00 GMT
• nebraska joins multi-state settlement against biohaven pharmaceutical for kickback allegations NORTHEAST - NEWS CHANNEL NEBRASKA Tue, 28 Jan 2025 22:06:45 GMT
• Pfizer settles Biohaven kickback claims case for $59.7m Pharmaceutical Technology Mon, 27 Jan 2025 08:00:00 GMT
• Pfizer shells out nearly $60M to resolve Nurtec kickback claims inherited in Biohaven buyout Fierce Pharma Mon, 27 Jan 2025 08:00:00 GMT
• Whistleblower Awarded $8.4 Million in Pfizer Settlement Whistleblower Network News Mon, 27 Jan 2025 08:00:00 GMT
• pfizer offers $60m to settle prescriber kickback claims pharmaphorum Mon, 27 Jan 2025 08:00:00 GMT
• pfizer agrees ~$60 million false claims settlement over nurtec odt The Pharma Letter Mon, 27 Jan 2025 08:00:00 GMT
• pfizer to pay more than $60 million for questionable marketing practices at biohaven Українські Національні Новини Sun, 26 Jan 2025 07:01:49 GMT
• pfizer to pay $59.7 million over kickbacks for migraine drug News Central TV Sat, 25 Jan 2025 08:00:00 GMT
• pfizer to pay more than $60 million for questionable marketing practices at biohaven Українські Національні Новини Sat, 25 Jan 2025 08:00:00 GMT
• Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors statnews.com Fri, 24 Jan 2025 08:00:00 GMT
• Pfizer Subsidiary Agrees to $59.7 Million Settlement Over Alleged Kickbacks to Healthcare Providers Law Commentary Fri, 24 Jan 2025 08:00:00 GMT
• Pfizer to pay $59.7 million over kickbacks for migraine drug Reuters Fri, 24 Jan 2025 08:00:00 GMT
• Pfizer to Pay $60 Million in Kickback, False Claims Settlement The Wall Street Journal Fri, 24 Jan 2025 08:00:00 GMT
• aimdu bio exports amb302 cancer treatment technology to biohaven in u.s. - chosunbiz Chosunbiz Tue, 14 Jan 2025 08:00:00 GMT
• Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conferenc... PR Newswire Mon, 13 Jan 2025 08:00:00 GMT
• biohaven & merus team up to develop novel bispecific adc therapies Contract Pharma Mon, 13 Jan 2025 08:00:00 GMT
• merus and biohaven announce collaboration to co-develop three novel bispecific adc programs Yahoo Finance Sun, 12 Jan 2025 08:00:00 GMT
• annexon strengthens board with commercial veteran bj jones ahead of late-stage drug launches StockTitan Fri, 10 Jan 2025 08:00:00 GMT
• annexon expands board of directors with appointment of commercial executive william 'bj” jones The Manila Times Fri, 10 Jan 2025 08:00:00 GMT
• Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire Tue, 07 Jan 2025 08:00:00 GMT
• Ropes & Gray Profiled in The American Lawyer for Winning Pharma and Health Care Corporate Practice of the Year Ropes & Gray LLP Fri, 20 Dec 2024 08:00:00 GMT
• biohaven's breakthrough: bhv-1300 achieves significant igg reduction, boosts immunotherapy market potential AInvest Tue, 17 Dec 2024 08:00:00 GMT
• Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; An... PR Newswire Mon, 16 Dec 2024 08:00:00 GMT
• biohaven pharma (bhvn) reports positive phase 1 degrader data StreetInsider.com Mon, 16 Dec 2024 08:00:00 GMT
• biohaven presents new data with bhv-7000 once-daily extended-release formulation demonstrating excellent safety profile and noncli... PR Newswire Fri, 06 Dec 2024 08:00:00 GMT
• biohaven pharma (bhvn) presents new data with bhv-7000 once-daily extended-release formulation demonstrating excellent safety prof... StreetInsider.com Fri, 06 Dec 2024 08:00:00 GMT
• biohaven’s sma trial miss bolsters scholar rock stock: analysts give verdicts, retail watches closely Stocktwits Mon, 25 Nov 2024 19:11:24 GMT
• biohaven pharma (bhvn) falls 13% following update on taldefgrobep alfa development program for spinal muscular atrophy and obesity... StreetInsider.com Mon, 25 Nov 2024 13:40:13 GMT
• biohaven pharma (bhvn) provides update on taldefgrobep alfa development program StreetInsider.com Mon, 25 Nov 2024 12:34:36 GMT
• Biohaven fails phase 3 SMA test but plans talks with FDA, plots move into obesity Fierce Biotech Mon, 25 Nov 2024 08:00:00 GMT
• Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity PR Newswire Mon, 25 Nov 2024 08:00:00 GMT
• Biohaven muscle drug misses goal of SMA study, but advances in obesity BioPharma Dive Mon, 25 Nov 2024 08:00:00 GMT
• Biohaven Drug Misses in Phase III for SMA, Will Be Tested in Obesity BioSpace Mon, 25 Nov 2024 08:00:00 GMT
• After SMA letdown, Biohaven's taldefgrobep finds new purpose in obesity FirstWord Pharma Mon, 25 Nov 2024 08:00:00 GMT
• scholar rock stock jumps as rival biohaven's muscle-wasting drug flunks pivotal study Yahoo Finance Mon, 25 Nov 2024 08:00:00 GMT
• biohaven's spinal muscular atrophy drug fails to meet study goal Reuters.com Mon, 25 Nov 2024 08:00:00 GMT
• multiple system atrophy market growth to accelerate in forecast period (2024-2034), delveinsight analyzes | ionis pharma, biohaven... The Globe and Mail Wed, 20 Nov 2024 22:22:51 GMT
• psoriasis market is expected to rise at a significant cagr, delveinsight | hangzhou highlightll pharmaceutical co., ltd, biohaven ... Barchart Wed, 20 Nov 2024 08:00:00 GMT
• generalized anxiety disorder market to reach new heights in growth by 2034, delveinsight predicts | fabre-kramer pharma, mind med,... The Globe and Mail Tue, 19 Nov 2024 08:00:00 GMT
• psoriasis market is expected to rise at a significant cagr, delveinsight | hangzhou highlightll pharmaceutical co., ltd, biohaven ... Barchart Mon, 18 Nov 2024 18:56:15 GMT
• biohaven reports third quarter 2024 financial results and recent business developments PR Newswire Tue, 12 Nov 2024 08:00:00 GMT
• two years after selling its migraine assets to pfizer in $13b deal, new haven-based biopharma trying to broaden its impact Hartford Business Journal Mon, 28 Oct 2024 07:00:00 GMT
• obsessive compulsive disorder market to show remarkable growth trends from 2024 to 2034, delveinsight reports | biohaven pharmaceu... The Globe and Mail Fri, 25 Oct 2024 14:28:00 GMT
• biohaven holds steady with $60 target on sma trial optimism by investing.com Investing.com UK Mon, 07 Oct 2024 07:00:00 GMT
• scholar rock scores with ‘surprise’ success in sma drug study BioPharma Dive Mon, 07 Oct 2024 07:00:00 GMT
• biohaven stock spikes after drug candidate to treat rare neurodegenerative disease shows promise MSN Fri, 04 Oct 2024 10:44:47 GMT
• finance watch: biopharma ipo queue grows as market conditions improve insights.citeline.com Fri, 04 Oct 2024 07:00:00 GMT
• biohaven pharma (bhvn) prices 5.26m share offering at $47.50/sh StreetInsider.com Tue, 01 Oct 2024 10:14:53 GMT
• biohaven aims to raise $250m; activist investor’s stake in galapagos exceeds 10% Endpoints News Tue, 01 Oct 2024 07:00:00 GMT
• after-hours movers: igm biosciences, biohaven pharma, acadia realty trust Investing.com India Tue, 01 Oct 2024 07:00:00 GMT
• Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine PR Newswire Mon, 30 Sep 2024 07:00:00 GMT
• biohaven pharma (bhvn) announces proposed $250m share offering StreetInsider.com Mon, 30 Sep 2024 07:00:00 GMT
• after-hours movers: igm biosciences, biohaven pharma, acadia realty trust by investing.com Investing.com South Africa Mon, 30 Sep 2024 07:00:00 GMT
• why biohaven pharmaceuticals will test the fda's regulatory limits statnews.com Thu, 26 Sep 2024 07:00:00 GMT
• Biohaven to Submit NDA for Troriluzole for All Spinocerebellar Ataxia Forms Following Positive Phase 3 Data Neurology Live Tue, 24 Sep 2024 07:00:00 GMT
• biohaven sets stage for comeback with pivotal study results in spinocerebellar ataxia BioSpace Tue, 24 Sep 2024 07:00:00 GMT
• biohaven’s real-world trial shows positive results for spinocerebellar ataxia drug OutSourcing-Pharma.com Tue, 24 Sep 2024 07:00:00 GMT
• biohaven stock soars on drug trial results: time to jump in? MarketBeat Tue, 24 Sep 2024 07:00:00 GMT
• Biohaven surges as genetic disease drug meets main study goal Reuters Mon, 23 Sep 2024 07:00:00 GMT
• Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA) PR Newswire Mon, 23 Sep 2024 07:00:00 GMT
• Biohaven bounces back with phase 3 ultra-rare disease win, heads to FDA in bid to overturn prior refusal Fierce Biotech Mon, 23 Sep 2024 07:00:00 GMT
• After setback, Biohaven to seek approval of neurological disorder drug BioPharma Dive Mon, 23 Sep 2024 07:00:00 GMT
• biohaven surges after delaying progression by up to 70% in a rare disease Investor's Business Daily Mon, 23 Sep 2024 07:00:00 GMT
• real-world data salvage biohaven drug, paving way for fda filing in neuro disease with no approved meds MedCity News Mon, 23 Sep 2024 07:00:00 GMT
• biohaven stock soars on positive results for rare neurological disease drug Investopedia Mon, 23 Sep 2024 07:00:00 GMT
• biohaven pharma (bhvn) reports positive topline results in pivotal study of troriluzole in spinocerebellar ataxia StreetInsider Mon, 23 Sep 2024 07:00:00 GMT
• biohaven stock spikes after drug candidate to treat rare neurodegenerative disease shows promise Benzinga Mon, 23 Sep 2024 07:00:00 GMT
• Fully booked: the Assembly lands public life sciences firm, now at full occupancy - Pittsburgh Business Times The Business Journals Wed, 18 Sep 2024 07:00:00 GMT
• psoriasis market is anticipated to rise at a notable cagr, estimates delveinsight | hangzhou highlightll pharmaceutical co., ltd, ... Barchart Thu, 05 Sep 2024 14:14:00 GMT
• do analysts think that biohaven pharmaceutical holding company ltd. (bhvn) is a good glp-1 and weight loss stock to invest in? Yahoo Finance Fri, 09 Aug 2024 00:21:00 GMT
• Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In? Yahoo Finance Thu, 08 Aug 2024 07:00:00 GMT
• biohaven reports second quarter 2024 financial results and recent business developments PR Newswire Thu, 08 Aug 2024 07:00:00 GMT
• new haven biohaven buys downtown building for $2.35 million Woodbridge Town News Wed, 03 Jul 2024 07:00:00 GMT
• biohaven teams with rutgers on cancer trial Hartford Business Journal Tue, 02 Jul 2024 11:51:41 GMT
• benitec biopharma announces appointment of kishen mehta to its board of directors GlobeNewswire Mon, 01 Jul 2024 07:00:00 GMT
• These microscopic tunnels are a goldmine for new medicines BioPharma Dive Thu, 27 Jun 2024 07:00:00 GMT
• pfizer's $11.6 billion biohaven buy could spark more biotech deals Yahoo Singapore News Thu, 27 Jun 2024 03:28:00 GMT
• new haven biohaven buys downtown building for $2.35 million Woodbridge Town News Tue, 25 Jun 2024 07:00:00 GMT
• nurtec (rimegepant) for the acute treatment of migraine Clinical Trials Arena Mon, 24 Jun 2024 07:00:00 GMT
• new haven biohaven buys downtown building for $2.35 million Woodbridge Town News Thu, 20 Jun 2024 20:23:59 GMT
• extracellular targeted protein degrader removes antibodies in first test in humans Nature Tue, 18 Jun 2024 07:00:00 GMT
Biohaven Pharmaceuticals(NYSE:BHVN) 
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive t...
Website: http://www.biohavenpharma.com
Founded: 2013
Full Time Employees: 647
CEO: Vlad Coric
Sector: Healthcare
Industry: Biotechnology